Luca Cicalese – Projects/Grants — UTMB Health Research Expert Profiles

View Scopus Profile

Emaillucicaleutmbedu

h-index

Research activity per year

If you made any changes in Pure these will be visible here soon.

6 Completed

6 results

Filter

Completed

Protocol No. ARQ197-A-U303 entitled "A Phase 3, Randomized, Double-Blind Study of Tivantinib (ARQ 197) in Subjects with MET Diagnostic-High Inoperable Hepatocellular Carcinoma (HCC) Treated with One Prior Systemic Therapy"
Cicalese, L.
3/22/13 → 5/1/16
Project: Other project
Protocol No. ARQ197-A-U303 entitled "A Phase 3, Randomized, Double-Blind Study of Tivantinib (ARQ 197) in Subjects with MET Diagnostic-High Inoperable Hepatocellular Carcinoma (HCC) Treated with One Prior Systemic Therapy"
Cicalese, L.
3/22/13 → 4/30/16
Project: Other project
Protocol No. ARQ197-A-U303 entitled "A Phase 3, Randomized, Double-Blind Study of Tivantinib (ARQ 197) in Subjects with MET Diagnostic-High Inoperable Hepatocellular Carcinoma (HCC) Treated with One Prior Systemic Therapy"
Cicalese, L.
Daiichi Sankyo
3/22/13 → 5/1/16
Project: Other project
Protocol No.: IM103076; Evaluating Nulojix Long Term Safety in Transplant, ENLIST Study: 203387
Cicalese, L.
Bristol-Myers Squibb Company
6/13/12 → 6/12/16
Project: Other project
Protocol No.: IM103076; Evaluating Nulojix Long Term Safety in Transplant, ENLIST Study: 203387
Cicalese, L.
6/13/12 → 6/12/16
Project: Other project
Protocol No.: IM103076; Evaluating Nulojix Long Term Safety in Transplant, ENLIST Study: 203387
Cicalese, L.
6/13/12 → 6/12/14
Project: Other project